Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization [NA]
Clinical trial update for dobutamine echocardiography in ischemic heart failure patients evaluated for revascularization; study completed wi…
-
FDA approval · 2021-04-02FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for ramipril (generic ACE inhibitor), enabling continued marketing with the…
-
FDA approval · 2021-04-02FDA Approved: RAMIPRIL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Ramipril from Rising Pharma Holdings, Inc., indicating an updated approval under the ANDA.
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Empagliflozin and Atrial Fibrillation Treatment [Phase 4]
A Phase 4 clinical trial update involving empagliflozin for atrial fibrillation treatment in patients with heart failure, obesity, and diabe…
-
FDA approval · 2021-03-30FDA Approved: METOLAZONE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approves the original ANDA for Metolazone from Unichem Pharmaceuticals (USA), Inc., establishing its generic status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-03-30FDA Approved: METOLAZONE — Original Application (Method Pharmaceuticals, LLC)
FDA approved METOLAZONE under an original ANDA from Method Pharmaceuticals, LLC (generic approval).
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart Failure [NA]
A completed clinical trial evaluating a pharmacist-led interdisciplinary program for patients with chronic heart failure; results posted in …
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads [NA]
A terminated clinical trial update for Sentus QP involving extended CRT evaluation with quadripolar left ventricular leads in heart failure …
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Adrecizumab Dose Escalation Safety and Tolerability Evaluation (ADESTE) [Phase 2]
Phase 2 dose-escalation study evaluating safety and tolerability of Adrecizumab (ADESTE) in acute heart failure; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: QP ExCELs: MultiPole Pacing (MPP) Sub-Study [NA]
A completed clinical trial update for Biotronik's QP ExCELs MPP sub-study in heart failure with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Exercise Training in Heart Failure: Changes in Cardiac Structure and Function [NA]
A completed clinical trial examining the effects of exercise training on cardiac structure and function in heart failure patients; results p…
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: An Assessment of Dual Site Left Ventricular Endocardial Pacing [NA]
A completed clinical trial assessing dual site left ventricular endocardial pacing in patients with atrial fibrillation and ventricular tach…
-
FDA approval · 2021-03-04FDA Approved: LISINOPRIL — Original Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC’s original application for lisinopril, a generic ACE inhibitor. Lisinopril is used to treat hypertension, con…
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Comparison Between NICOM-Cheetah and Flotrac-Vigileo for Cardiac Output Monitoring.
A terminated clinical trial comparing NICOM-Cheetah and Flotrac-Vigileo for cardiac output monitoring.
-
FDA approval · 2021-02-26FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for spironolactone from Mylan Pharmaceuticals, resulting in changes to the product labeling as p…
-
FDA approval · 2021-02-26FDA Approved: SPIRONOLACTONE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's generic spironolactone. This action confirms approval of modifications under…
-
FDA approval · 2021-02-26FDA Approved: SPIRONOLACTONE — Supplemental Application (Oxford Pharmaceuticals, LLC)
The FDA approved a supplemental application for spironolactone from Oxford Pharmaceuticals, LLC, under the existing ANDA.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Preoperative Parenteral Thiamine Supplementation in Patients Undergoing Heart Surgery [Phase 4]
Phase 4 clinical trial update evaluating preoperative parenteral thiamine supplementation in patients undergoing heart surgery.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients [NA]
A completed clinical trial investigating motivational interviewing to improve self-care in heart failure patients; results posted in 2021.
-
FDA approval · 2021-02-19FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide by Prasco Laboratories, authorizing its marketing as …
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: MultiPoint Pacing™ Post Market Study
Post-market study update for MultiPoint Pacing in heart failure; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Heart Function in Patients Assessed for Sleep Apnoea
A completed clinical trial updating heart function in patients assessed for sleep apnea; results posted in 2021.
-
FDA approval · 2021-02-16FDA Approved: ENTRESTO — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for ENTRESTO (sacubitril and valsartan) from Novartis Pharmaceuticals Corporation. This action repre…
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance [Phase 4]
Phase 4 trial comparing metolazone to chlorothiazide for acute decompensated heart failure with diuretic resistance; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Early Elimination of Premature Ventricular Contractions in Heart Failure [NA]
A terminated clinical trial update on early elimination of premature ventricular contractions in patients with congestive heart failure; res…